Clinical Trial Update: Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating carbamazepine for prevention of chemotherapy-induced nausea and vomiting, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Carbamazepine (Carbamazepine)

Snippet

Sponsor: Faculdade de Medicina do ABC | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: UNKNOWN